REVLANTE
DEAD

Serial Number

79233960

Owner

NOVARTIS AG

Filing Date

Mar 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

REVLANTE Trademark

Serial Number: 79233960 • Registration: 6191892

REVLANTE is a trademark filed by NOVARTIS AG on March 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 24, 2018

Registration Date

November 10, 2020

Published for Opposition

August 25, 2020

Cancellation Date

August 7, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Aug 11, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2023 FINP
FINAL DECISION PROCESSED AND SENT TO IB
Dec 28, 2022 FISN
REGISTERED-PRINCIPAL REGISTER
Nov 10, 2020 R.PR
PUBLISHED FOR OPPOSITION
Aug 25, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 5, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 5, 2020 OP2R
NOTICE OF PUBLICATION
Aug 5, 2020 NPUB
ELECTRONIC RECORD REVIEW COMPLETE
Jul 21, 2020 FIXD
ATTORNEY REVIEW COMPLETED
Jul 21, 2020 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jul 16, 2020 CREV
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 3, 2020 ERRR
REG. CANCELLED - RESTORED TO PENDENCY
May 27, 2020 CRTP
ASSIGNED TO PETITION STAFF
May 27, 2020 APET
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
May 26, 2020 RCII
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 16, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 3, 2019 GPAR
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 20, 2018 CRCV
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Nov 2, 2018 GPNX
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2018 OP2R
NOTICE OF PUBLICATION
Aug 29, 2018 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 5, 2018 PBCR
NOTICE OF PUBLICATION
Jul 4, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 19, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 7, 2018 SDRC